Multifunctional fluorescent titania nanoparticles: green preparation and applications as antibacterial and cancer theranostic agents
Source abstract
Abstract
Theranostic nanoparticles have attracted considerable attention in recently revolutionized medicine. Since the last decade, there has been a growing attempt to design various theranostic nanoparticles but difficulties still exist in the fabrication of their biocompatible one. Herein, fluorescent titania nanoparticles (FTN) were fabricated using a one-step green method. This FTN had ultra-high doxorubicin hydrochloride (DOX) loading capacity (encapsulation efficiency 95.50% and loading content 38.20%) that release the loaded drug in response to acidic pH. In vitro cytotoxicity experiments on human osteosarcoma (SaOs-2) and breast cancer (MCF-7) cell lines revealed superior anticancer efficacy (lowered the IC50 concentration by 3- and 5.5-fold for SaOs-2 and MCF-7 cells, respectively) and also better imaging for intracellular tracking of DOX/FTN relative to free DOX. Furthermore, the prepared nanoparticles showed efficient antibacterial activity against both gram-negative (Escherichia coli ATCC 25922) and gram-positive (Staphylococcus aureus ATCC 25923) bacteria. In this study, we have developed novel theranostic titania nanoparticles with inherent fluorescence property for cancer imaging and therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran;
Cell and Molecular Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran;
Center of Nano Research, Ferdowsi University of Mashhad, Mashhad, Iran;
Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
Funding
Ferdowsi University of Mashhad
References (50)
Show source-provided references
1. 10.1016/j.msec.2017.10.00410.1016/j.msec.2017.10.004 ↗
2. 10.1002/smll.20160063510.1002/smll.201600635 ↗
3. 10.1016/j.drudis.2015.05.00910.1016/j.drudis.2015.05.009 ↗
4. 10.1016/j.msec.2017.03.02710.1016/j.msec.2017.03.027 ↗
5. 10.2174/138161282366617021412241310.2174/1381612823666170214122413 ↗
6. Chen Y · Int J Nanomed · 2011 · 6 · 2321
7. 10.1007/s12274-017-1654-810.1007/s12274-017-1654-8 ↗
8. 10.3109/21691401.2012.75912210.3109/21691401.2012.759122 ↗
9. 10.3109/21691401.2016.116040310.3109/21691401.2016.1160403 ↗
10. 10.1128/AEM.71.7.3427-3432.200510.1128/AEM.71.7.3427-3432.2005 ↗
11. Jorgensen JH, Turnidge JD. Susceptibility test methods: dilution and disk diffusion methods. Manual of clinical microbiology. 11th ed. Washington (DC): American Society of Microbiology; 2015. p. 1253–1273 .10.1128/9781555817381.ch71 ↗
12. 10.1080/21691401.2017.130440210.1080/21691401.2017.1304402 ↗
13. 10.3109/21691401.2015.112962810.3109/21691401.2015.1129628 ↗
14. 10.1039/C7NR04039C10.1039/C7NR04039C ↗
15. 10.1016/j.colsurfa.2015.03.03710.1016/j.colsurfa.2015.03.037 ↗
16. 10.1016/j.colsurfb.2017.07.00610.1016/j.colsurfb.2017.07.006 ↗
17. 10.1016/j.apcatb.2017.06.03910.1016/j.apcatb.2017.06.039 ↗
18. 10.1039/C6RA22163G10.1039/C6RA22163G ↗
19. 10.1016/j.saa.2012.12.08310.1016/j.saa.2012.12.083 ↗
20. 10.1021/acsnano.6b0774610.1021/acsnano.6b07746 ↗
21. 10.1155/2010/78017110.1155/2010/780171 ↗
22. 10.1039/c3tb21362e10.1039/c3tb21362e ↗
23. 10.1186/1477-3155-7-510.1186/1477-3155-7-5 ↗
24. 10.3390/catal608011710.3390/catal6080117 ↗
25. 10.1039/C6TC01920J10.1039/C6TC01920J ↗
26. 10.1021/acsami.6b1637310.1021/acsami.6b16373 ↗
27. 10.1038/srep3524310.1038/srep35243 ↗
28. 10.2967/jnumed.114.14601910.2967/jnumed.114.146019 ↗
29. 10.1016/j.jcis.2016.05.00110.1016/j.jcis.2016.05.001 ↗
30. 10.3109/21691401.2014.94245710.3109/21691401.2014.942457 ↗
31. 10.1049/mnl.2016.006510.1049/mnl.2016.0065 ↗
32. 10.1016/j.jhazmat.2014.08.07310.1016/j.jhazmat.2014.08.073 ↗
33. 10.1016/j.cattod.2010.11.05510.1016/j.cattod.2010.11.055 ↗
34. 10.1007/s11051-013-1432-910.1007/s11051-013-1432-9 ↗
35. 10.3109/17435390.2012.74293510.3109/17435390.2012.742935 ↗
36. 10.1016/j.jphotobiol.2017.05.00310.1016/j.jphotobiol.2017.05.003 ↗
37. 10.1016/j.colsurfb.2017.03.05410.1016/j.colsurfb.2017.03.054 ↗
38. 10.1039/C5SC00792E10.1039/C5SC00792E ↗
39. 10.20546/ijcmas.2017.603.28110.20546/ijcmas.2017.603.281 ↗
40. 10.1080/21691401.2017.140812110.1080/21691401.2017.1408121 ↗
41. 10.1039/c3ra42863j10.1039/c3ra42863j ↗
42. 10.1016/j.bmcl.2017.01.04810.1016/j.bmcl.2017.01.048 ↗
43. 10.1039/c3nr33695f10.1039/c3nr33695f ↗
44. 10.3390/ijms1505821610.3390/ijms15058216 ↗
45. 10.1038/srep3019610.1038/srep30196 ↗
46. 10.1007/s00436-015-4838-810.1007/s00436-015-4838-8 ↗
47. 10.1039/c1jm13615a10.1039/c1jm13615a ↗
48. 10.1038/srep3072910.1038/srep30729 ↗
49. 10.1039/c1cc10659g10.1039/c1cc10659g ↗
50. 10.1016/j.nano.2010.09.00410.1016/j.nano.2010.09.004 ↗